Download the appMore options
PisaczekSearch
文AEN-US
Vitamins and minerals

Vitamin C by IV drip? Why it is not in hospital guidelines

Sources: 14 · Article: 17 561 characters ↓

What do Natural Therapy Specialists write?

Jerzy Zięba

Intravenous vitamin C is not included in official guidelines for COVID-19 and sepsis, and doctors reject requests to use such protocols.

„Vitamin C is currently not included in the official guidelines for doctors on treating COVID-19 and sepsis. None of the methods and protocols for using vitamin C to treat COVID-19 and sepsis have been recognized by the Polish medical community, and they are not used. Reports about their effectiveness have not yet gained the support of scientists and practitioners in Poland. Patients’ attempts to persuade doctors to use vitamin C-based treatment protocols are rejected by doctors.”Witamina C nie znajduje się obecnie w oficjalnych wytycznych dla lekarzy na temat leczenia COVID-19 i sepsy. Wszystkie metody i protokoły dotyczące stosowania witaminy C w leczenie COVID-19 i sepsy nie zostały uznane przez polskie środowisko medyczne i nie są stosowane. Doniesienia na temat ich skuteczności nie zyskały jak dotąd poparcia naukowców i praktyków w Polsce. Próby podejmowane przez pacjentów polegające na przekonaniu lekarzy do zastosowania protokołów terapeutycznych opartych na witaminie C są odrzucane przez lekarzy.
Andrzej Frydrychowski

Andrzej Frydrychowski describes past cases of treatment with intravenous vitamin C and claims it was sidelined in favor of more expensive drugs.

„Yes, because vitamin C was used and permitted in those years. Then much more expensive antibiotics and other drugs came to the fore. Vitamin C was cast aside because it was too effective and too cheap. There are tens of thousands of publications on this vitamin, including many from the last few years.”Owszem, ponieważ w tamtych latach witamina C była stosowana i dozwolona. Potem do głosu doszły dużo droższe antybiotyki i inne leki. Witamina C została wyrzucona do kąta, bo była zbyt skuteczna i zbyt tania. Na temat tej witaminy są dziesiątki tysięcy pozycji, również wiele z ostatnich paru lat.
Jerzy Zięba

Jerzy Zięba claims that no studies have been conducted in Poland to determine the effectiveness of the methods he describes, and that researchers abroad are studying intravenous vitamin C.

„At the time of the greatest criticism of the information I presented, no one in Poland had conducted studies that would constructively, based on results and findings, conclusively assess the methods I presented. Numerous articles insulting me took their place. This has still not happened to this day.”W czasie największej krytyki zaprezentowanych przeze mnie informacji nikt w Polsce nie przeprowadził badań, które w sposób konstruktywny, oparty na wynikach i rezultatach ostatecznie rozstrzygnęłyby przedstawione przeze mnie metody. Ich miejsce zajęły liczne artykułu obrażające mnie. Nie stało się to do dziś.
Jerzy Zięba

Jerzy Zięba cites a recommendation that doctors investigate the possible use of supplemental vitamin C to fight viral infections.

„To effectively fight the new SARS-CoV-2 virus, doctors should investigate readily available pharmaceutical and nutritional treatments with proven antioxidant, anti-inflammatory, and immunosuppressive properties. Supplemental vitamin C may also provide additional benefits in preventing viral infections, shortening the course of illness, and reducing complications – source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553131/.”Aby skutecznie walczyć z nowym wirusem SARS-CoV-2, lekarze powinni zbadać łatwo dostępne farmaceutyczne i odżywcze środki terapeutyczne o udowodnionych właściwościach przeciwutleniających, przeciwzapalnych i immunosupresyjnych. Uzupełniająca witamina C może również zapewnić dodatkowe korzyści w zapobieganiu infekcjom wirusowym, skrócić przebieg choroby i zmniejszyć powikłania choroby – źródło: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553131/.
Jerzy Zięba

Jerzy Zięba describes intravenous vitamin C being given to nine people with advanced pancreatic cancer; their disease did not progress for six months after the treatment.

„This treatment method was used in 9 patients with advanced pancreatic tumors. While they were receiving chemotherapy, they were given intravenous vitamin C for a month. Their disease did not progress during the six months after the treatment ended. We need more experiments and studies like this, as well as publications.”Tę metodę leczenia zastosowano u 9 pacjentów z zaawansowanym guzem trzustki. Przy stosowaniu chemioterapii, podawano im przez miesiąc witaminę C dożylnie. Choroba nie poczyniła postępów w ich organizmach w ciągu pół roku od zakończenia kuracji. Aby więcej takich eksperymentów i badań, a także publikacji.
Jerzy Zięba

Jerzy Zięba points out that an article about COVID-19 described high-dose intravenous vitamin C as promising, although it had not been incorporated into medical protocols.

„From the article, you will learn that vitamin C does not cure, but you will also learn that high doses of intravenous vitamin C are promising for treating COVID-19. Does that tell you anything? The article is dated October 13, 2020. It was published 7 months after I presented to you in March the information I had gathered about methods for treating COVID-19 and substances that, according to doctors, should be used in medical protocols.”Z artykułu dowiecie się, że witamina C nie leczy, jak również dowiecie się, że wysokie dawki witaminy C podawane dożylnie są obiecujące w leczeniu COVID-19. Coś Wam to mówi? Artykuł jest z 13 października 2020 roku. Został opublikowany 7 miesięcy po tym jak w marcu przedstawiłem Wam zebrane informacje na temat metod leczenia COVID-19 i substancji, które zdaniem lekarzy powinny być wykorzystywane w procedurach medycznych.
Jerzy Zięba

Jerzy Zięba notes that views on using vitamin C for COVID-19 are contradictory, and claims that publications and analyses indicate it is effective.

„In the article dated October 13, 2020, you will read that there are reports about vitamin C being used in COVID-19 treatments. In the one dated October 19, you will read that this is a myth and that there is no evidence that high doses of vitamin C can help prevent or treat coronavirus.”W tym z 13 października 2020 roku przeczytacie, że są doniesienia na temat witaminy C wykorzystywanej w terapiach przy COVID-19. W tym z 19 października przeczytacie, że to mit i że nie ma dowodów na to, że duże dawki witaminy C mogą być pomocne w zapobieganiu i leczeniu koronawirusa.
Thomas E. Levy

Thomas E. Levy believes that doctors should consider treatment with vitamin C, hydrocortisone, and thiamine, and that refusal is justified only for treatment that is expensive, toxic, or questionably effective.

„Effective When a treatment is very expensive, significantly toxic, and/or questionably effective, there may be a legitimate medicolegal argument for withholding it. NONE of these considerations apply to Dr. Marik’s cocktail of vitamin C, hydrocortisone, and thiamine.”Effective When a treatment is very expensive, significantly toxic, and/or questionably effective, a legitimate medicolegal argument can be made to withhold such a treatment. NONE of these considerations apply to Dr. Marik’s cocktail of vitamin C, hydrocortisone, and thiamine.
Thomas E. Levy

Thomas E. Levy urges people to demand that the Thomas E. Levy protocol be used for a person with sepsis and describes the possibility of taking legal action if it is refused.

„Bottom line: If you have a family member dying of sepsis in an intensive care unit, demand that Dr. Marik’s protocol be started immediately. If this option is denied, make sure your physician understands that immediate legal action to initiate the therapy will follow, and that the death of your loved one will ensure that a malpractice suit is brought against him or her.”Bottom line: If you have a family member dying of sepsis on an intensive care unit, demand that Dr. Marik’s protocol be immediately instituted. If you are denied this option, make sure your physician understands that immediate legal action to initiate the therapy will ensue, and that the death of your loved one will assure the initiation of a malpractice suit against him/her.

What does scientific research from PubMed · Europe PMC say?

We selected 7 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 749.

Aim of the study: Intravenous vitamin C (IVC) is a contentious adjunctive cancer therapy, widely used in naturopathic and integrative oncology settings. We conducted a systematic review of human interventional and observational studies assessing IVC for use in cancer patients.

Results: Of 897 records, a total of 39 reports of 37 studies were included: 2 randomized controlled trials (RCTs), 15 uncontrolled trials, 6 observational studies, and 14 case reports. IVC dosing ranged from 1 g to more than 200 g ascorbic acid per infusion, typically administered 2 to 3 times weekly. IVC does not appear to increase toxicity or interfere with the antitumor effects of gemcitabine/erlotinib therapy or paclitaxel and carboplatin. Based on 1 RCT and data from uncontrolled human trials, IVC may improve time to relapse and possibly enhance reductions in tumor mass and improve survival in combination with chemotherapy. IVC may improve quality of life, physical function, and toxicities associated with chemotherapy, including fatigue, nausea, insomnia, constipation, and depression. Case reports document several instances of tumor regression and long-term disease-free survival associated with use of IVC. There is limited high-quality clinical evidence on the safety and effectiveness of IVC.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Vitamin C is known to support immune function and is accumulated by neutrophils to millimolar intracellular concentrations, suggesting an important role for the vitamin in these cells. In this review, the effects of vitamin C, as a mono- or multi-supplement therapy, on neutrophil function were assessed by conducting a systematic review of randomized controlled trials (RCTs).

Results: Overall, 44% of the RCTs assessed in this review showed effects of vitamin C supplementation on neutrophil functions. However, the studies were very heterogeneous, comprising different participant cohorts and different dosing regimens. There were also a number of limitations inherent in the design of many of these RCTs. Future RCTs should incorporate prescreening of potential participants for low vitamin C status or use cohorts known to have low vitamin status, such as hospitalized patients, and should also include vitamin C dosing appropriate for the cohort under investigation.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have poor 5-year survival. Pharmacological ascorbate (P-AscH-, high dose, intravenous, vitamin C) has shown promise as an adjunct to chemotherapy. We hypothesized that adding P-AscH- to gemcitabine and nab-paclitaxel would increase survival in patients with metastatic PDAC.

Results: Intravenous P-AscH- increased serum ascorbate levels from micromolar to millimolar levels. P-AscH- added to gemcitabine + nab-paclitaxel (ASC) increased overall survival to 16 months compared with 8.3 months with gemcitabine + nab-paclitaxel (SOC) (HR = 0.46; 90 % CI 0.23, 0.92; p = 0.030). Median progression-free survival was 6.2 months (ASC) vs. 3.9 months (SOC) (HR = 0.43; 90 % CI 0.20, 0.92; p = 0.029). Adding P-AscH- did not negatively affect quality of life or increase the frequency or severity of adverse events. P-AscH- infusions of 75 g three times weekly in patients with metastatic pancreatic cancer prolong overall and progression-free survival without reducing quality of life or adding toxicity (ClinicalTrials.gov number NCT02905578).

Money for the studycompany together with others · National Institutes of Health, Holden Comprehensive Cancer Center
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?unknown
Type of studystudy with random allocation to groups (RCT)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The global burden of sepsis is estimated at 15 to 19 million cases annually, with a mortality rate approaching 60% in low-income countries.

Results: There were 47 patients in both the treatment and control groups, with no significant differences in baseline characteristics between the two groups. Hospital mortality was 8.5% (4 of 47) in the treatment group compared with 40.4% (19 of 47) in the control group (P < .001). The propensity-adjusted odds of mortality in patients treated with the vitamin C protocol was 0.13 (95% CI, 0.04-0.48; P = .002). The Sepsis-Related Organ Failure Assessment score decreased in all patients in the treatment group, with none developing progressive organ failure. All patients in the treatment group were weaned off vasopressors, an average of 18.3 ± 9.8 h after starting treatment with the vitamin C protocol. The mean duration of vasopressor use was 54.9 ± 28.4 h in the control group (P < .001).

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Previous studies mentioned the beneficial effects of vitamin C on hemorrhage and wound healing. We evaluated the effects of vitamin C on hemorrhage, hemoglobin concentration, and wound complications in total abdominal hysterectomy.

Results: The mean age of the participants was 37.8 ± 4.8 years, with a mean preoperative plasma vitamin C concentration of 5.07 ± 2.1 mg/dL, close to subclinical deficiency. The baseline characteristics of both groups were the same. The hemorrhage volume was slightly higher in the control group (345.2 ± 31.8 ml vs. 388.1 ± 28.3 ml, P < 0.001). Intravenous vitamin C administration had a positive effect on reducing hemorrhage during total abdominal hysterectomy.

Money for the studyuniversity or foundation · National Nutrition and Food Technology Research Institute
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studystudy with random allocation to groups (RCT)
Participants80

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Chikungunya is a viral illness characterized by severe joint pain, which may persist for months to years. There is no effective treatment for this disease.

Results: We treated 56 patients with moderate to severe persistent pain with a single infusion of ascorbic acid ranging from 25-50 grams and hydrogen peroxide (3 cc of a 3% solution) from July to October 2014. Patients were asked about their pain using the Verbal Numerical Rating Scale-11 immediately before and after treatment. The mean pain score before and after treatment was 8 and 2 respectively (60%) (p < 0.001); and 5 patients (9%) had a pain score of 0. The use of intravenous ascorbic acid and hydrogen peroxide resulted in a statistically significant reduction in pain in patients with moderate to severe pain from the Chikungunya virus immediately after treatment.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyclinical study in people
Participants56

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Cerebrovascular endothelial function can be assessed by measuring the shear-mediated dilation or cerebrovascular reactivity (CVR) of the internal carotid artery (ICA) in response to transient hypercapnia (30 s). ICA CVR is blunted with aging; however, it is not known whether age-related reductions in ICA CVR are influenced by antioxidant-responsive mechanisms.

Results: The primary analytic sample included nine Y adults (25 ± 2 years) and nineteen (65 ± 6 years) MA/O adults, with analyzable data varying by outcome. ICA CVR was measured using high-resolution duplex ultrasound, and MCA CVR was measured using transcranial Doppler ultrasound. AA infusion improved ICA CVR and MCA CVR in MA/O adults but had no effect in Y adults. These findings suggest that age-related impairments in cerebrovascular function may be partly attributable to mechanisms responsive to acute, supraphysiological AA administration.

Money for the studygovernment, public institutions · HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Institute on Aging (NIA)
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyclinical study in people

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„Fowler et al., Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis, Journal of Translational Medicine, 2014; 12: 32 (Epub 2014 January 31), doi: 10.1186/1479-5876-12-32 Description [23]: This was the first RCT to investigate IV-C for severe sepsis (septic shock). It detected significant IV-C dose-dependent reductions in SOFA scores and no adverse events in patients receiving IV-C. The following quote is from the abstract: "No adverse safety events were observed in ascorbic acid-infused patients.”Fowler et al., Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis, Journal of Translational Medicine, 2014; 12: 32 (Epub 2014 January 31), doi: 10.1186/1479-5876-12-32 Description [23]: This was the first RCT to investigate IV-C for severe sepsis (septic shock). It detected significant IV-C dose dependent reductions in SOFA scores and no adverse events in patients receiving IV-C. Following quote is from the abstract: "No adverse safety events were observed in ascorbic acid-infused patients.
Orthomolecular Medicine News Service
„(2011) Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med 9:25. Cisternas P, Silva-Alvarez C, Martinez F, et al. (2014) The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism. J Neurochem 129: 663-671. Wang Y, Lin H, Lin BW, et al. (2019) Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Ann Intensive Care 9:58. Boretti A, Banik BK. (2020) Intravenous vitamin C for reduction of cytokine storm in acute respiratory distress syndrome. PharmaNutrition 12:100190. Iglesias J, Vassallo AV, Patel V et al.”(2011) Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med 9:25. Cisternas P, Silva-Alvarez C, Martinez F, et al. (2014) The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism. J Neurochem 129: 663-671. Wang Y, Lin H, Lin BW, et al. (2019) Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Ann Intensive Care 9:58. Boretti A, Banik BK. (2020) Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome. PharmaNutrition 12:100190. Iglesias J, Vassallo AV, Patel V et al.
Orthomolecular Medicine News Service
„(1971) Observations on the Dose and Administration of Ascorbic Acid When Employed Beyond the Range of a Vitamin in Human Pathology. J Applied Nutrition 23:61-87. Lee RE. (1961) Ascorbic Acid and the Peripheral Vascular System. Ann N Y Acad Sci. 92:295-301. Lee RE, Holze EA. (1951) Nutritional factors in hemodynamics: dissociation of pressor response and hemorrhage resistance in avitaminosis C. Proc Soc Exp Biol Med. 76:325-329. Barabutis N, Khangoora V, Marik PE, Catravas JD. (2017) Hydrocortisone and Ascorbic Acid synergistically protect and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest 152:954-962.”(1971) Observations on the Dose and Administration of Ascorbic Acid When Employed Beyond the Range of a Vitamin in Human Pathology. J Applied Nutrition 23:61-87. Lee RE. (1961) Ascorbic Acid and the Peripheral Vascular System. Ann N Y Acad Sci. 92:295-301. Lee RE, Holze EA. (1951) Nutritional factors in hemodynamics: dissociation of pressor response and hemorrhage resistance in avitaminosis C. Proc Soc Exp Biol Med. 76:325-329. Barabutis N, Khangoora V, Marik PE, Catravas JD. (2017) Hydrocortisone and Ascorbic Acid synergistically protect and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest 152:954-962.

Sources (14)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.